pseudomonas-aeruginosa

Documents about pseudomonas-aeruginosa

• MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia#1409344ClinicalTrials.gov
• Pseudomonas aeruginosa#349837CaltechDATA
• Pseudomonas aeruginosa mut#366476CaltechDATA
• Pseudomonas aeruginosa mut24#1124195CaltechDATA
• Pseudomonas aeruginosa_hypo/-N#1170123CaltechDATA
• Pseudomonas_aeruginosa_DfliP#1085155CaltechDATA
• Bacteriophage Effects on Pseudomonas Aeruginosa#1114488ClinicalTrials.gov
• Targeting Pseudomonas aeruginosa with a lytic bacteriophage combination#249947edoc-Server
• Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis#127642ClinicalTrials.gov
• Phenotypic and Genotypic Characteristics of Pseudomonas Aeruginosa Isolates in Sohag University Hospitals#172344ClinicalTrials.gov
• Pseudomonas aeruginosa delta-exsD#361634CaltechDATA
• Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.#807688ClinicalTrials.gov
• Monotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas Aeruginosa#424208ClinicalTrials.gov
• Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection#1465858ClinicalTrials.gov
• Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa Pneumonia#1170660ClinicalTrials.gov
• Azobenzene-bridged potent divalent ligands of Pseudomonas aeruginosa LecA#1146628HAL (France)
• Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa#253020ClinicalTrials.gov
• The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis#879537ClinicalTrials.gov
• Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections#1437202ClinicalTrials.gov
• Characterization and Evaluation of Bacteriophages ΦPa-C and ΦPa-Tc Infecting Pseudomonas aeruginosa#307630DigitalCommons@Kennesaw State University
• OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis#1444427ClinicalTrials.gov
• Distinct transcriptional logics of catechol siderophore transporters in Pseudomonas aeruginosa for efficient iron acquisition#635272HAL (France)
• wt P. aeruginosa#1319350CaltechDATA
• Pseudomonas aeruinosa#640320CaltechDATA
• Pseudomonas aerugionsa PAO1#1442527CaltechDATA
• Bacteriophage therapy for Pseudomonas aeruginosa biofilms: mechanisms of resistance and novel treatment strategies#366765Dbt
• Adaptation to cinnamaldehyde shapes Pseudomonas aeruginosa resistance to major antibiotics#1379661HAL (France)
• Investigating the mechanism used by Pyocin S3 to target and kill susceptible Pseudomonas aeruginosa strains#1148731University of Nottingham Repository
• Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients#833056ClinicalTrials.gov
• Pseudomonas aeruginoas_JT2944#349835CaltechDATA
• twitching Pseudomonas WT#363444CaltechDATA
• Pseudomonas full length aer2#363450CaltechDATA
• Pseudomonas Aeruginosa Infections Among COVID-19 Patients in Intensive Care Units at CHRU of Nancy (Pyo-COVID-3)#208490ClinicalTrials.gov
• Infections bactériennes et interactions microbiennes : études « omiques » de Staphylococcus aureus et de Pseudomonas aeruginosa#220589HAL (France)
• Studying Pseudomonas aeruginosa pathogenesis: the need for more than just the PAO1 strain#405854HAL (France)
• P. aeruginosa T6SS minicell#363452CaltechDATA
• twitching Pseudomonas delta-pilH#363443CaltechDATA
• twitching Pseudomonas delta-pilH#363463CaltechDATA
• A novel isolated phage targeting <i>Pseudomonas aeruginosa</i> demonstrates therapeutic potential#180466PLOS
• Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)#907744ClinicalTrials.gov
• Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies#454050ClinicalTrials.gov
• Role of Pseudomonas Aeruginosa Biofilms in Exacerbations in Patients With Bronchiectasis With and Without Chronic Obstructive Pulmonary Disease#158013ClinicalTrials.gov
• Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration#979146ClinicalTrials.gov
• Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa#1320483ClinicalTrials.gov
• Permeabilize, but Choose Wisely: Selective Antibiotic Potentiation Through Outer Membrane Disruption in Pseudomonas aeruginosa#1379659HAL (France)
• P_aeruginosa_PA14_DfliF_Krios#356439CaltechDATA
• P aeruginosa del-exsD mutants#1161212CaltechDATA
• P aeruginosa del-exsD mutants#1161229CaltechDATA
• Translation quality control in Pseudomonas aeruginosa: current knowledge and perspectives#153687HAL (France)
• PW 1305#1044098CaltechDATA